These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31554551)

  • 1. Benign Breast Disease in Women.
    Stachs A; Stubert J; Reimer T; Hartmann S
    Dtsch Arztebl Int; 2019 Aug; 116(33-34):565-574. PubMed ID: 31554551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.
    Richter-Ehrenstein C; Maak K; Röger S; Ehrenstein T
    BMC Cancer; 2018 Aug; 18(1):829. PubMed ID: 30115017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate?
    Carder PJ; Liston JC
    J Clin Pathol; 2003 Feb; 56(2):133-8. PubMed ID: 12560393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.
    Dillon MF; McDermott EW; Hill AD; O'Doherty A; O'Higgins N; Quinn CM
    Ann Surg Oncol; 2007 Feb; 14(2):704-11. PubMed ID: 17151788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up.
    Simsir A; Waisman J; Thorner K; Cangiarella J
    Cancer; 2003 Jun; 99(3):156-65. PubMed ID: 12811856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radial scars in benign breast-biopsy specimens and the risk of breast cancer.
    Jacobs TW; Byrne C; Colditz G; Connolly JL; Schnitt SJ
    N Engl J Med; 1999 Feb; 340(6):430-6. PubMed ID: 9971867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
    El-Sayed ME; Rakha EA; Reed J; Lee AH; Evans AJ; Ellis IO
    Histopathology; 2008 Dec; 53(6):650-7. PubMed ID: 19076681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
    Rakha EA; Lee AH; Jenkins JA; Murphy AE; Hamilton LJ; Ellis IO
    Int J Cancer; 2011 Sep; 129(6):1417-24. PubMed ID: 21128240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of papillary lesions without atypia of the breast diagnosed on needle biopsy.
    Yu Y; Salisbury E; Gordon-Thomson D; Yang JL; Crowe PJ
    ANZ J Surg; 2019 May; 89(5):524-528. PubMed ID: 30414221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S3-Guidelines for the Treatment of Inflammatory Breast Disease during the Lactation Period: AWMF Guidelines, Registry No. 015/071 (short version) AWMF Leitlinien-Register Nr. 015/071 (Kurzfassung).
    Jacobs A; Abou-Dakn M; Becker K; Both D; Gatermann S; Gresens R; Groß M; Jochum F; Kühnert M; Rouw E; Scheele M; Strauss A; Strempel AK; Vetter K; Wöckel A
    Geburtshilfe Frauenheilkd; 2013 Dec; 73(12):1202-1208. PubMed ID: 24771901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancy rates of B3-lesions in breast magnetic resonance imaging - do all lesions have to be excised?
    Preibsch H; Wanner LK; Staebler A; Hahn M; Siegmann-Luz KC
    BMC Med Imaging; 2018 Sep; 18(1):27. PubMed ID: 30200900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesions of uncertain malignant potential in the breast (B3): what do we know?
    Purushothaman HN; Lekanidi K; Shousha S; Wilson R
    Clin Radiol; 2016 Feb; 71(2):134-40. PubMed ID: 26607917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An audit of "equivocal" (C3) and "suspicious" (C4) categories in fine needle aspiration cytology of the breast.
    Deb RA; Matthews P; Elston CW; Ellis IO; Pinder SE
    Cytopathology; 2001 Aug; 12(4):219-26. PubMed ID: 11488870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.
    Neal L; Sandhu NP; Hieken TJ; Glazebrook KN; Mac Bride MB; Dilaveri CA; Wahner-Roedler DL; Ghosh K; Visscher DW
    Mayo Clin Proc; 2014 Apr; 89(4):536-47. PubMed ID: 24684875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large volume "mammotome" biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast.
    Carder PJ; Khan T; Burrows P; Sharma N
    J Clin Pathol; 2008 Aug; 61(8):928-33. PubMed ID: 18495791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3).
    Lee AH; Denley HE; Pinder SE; Ellis IO; Elston CW; Vujovic P; Macmillan RD; Evans AJ;
    Histopathology; 2003 Apr; 42(4):331-6. PubMed ID: 12653944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous large-core biopsy of papillary breast lesions.
    Liberman L; Bracero N; Vuolo MA; Dershaw DD; Morris EA; Abramson AF; Rosen PP
    AJR Am J Roentgenol; 1999 Feb; 172(2):331-7. PubMed ID: 9930777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Papillary lesions of the breast: diagnostic imaging and contribution of percutaneous needle biopsy with 14G needle].
    Bazzocchi M; Berra I; Francescutti GE; Del Frate C; Zuiani C; Puglisi F; Di Loreto C
    Radiol Med; 2001 Jun; 101(6):424-31. PubMed ID: 11479438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological evaluation of papillary lesions of the breast from needle biopsy to the excised specimen: a single institutional experience.
    Gilani S; Tashjian R; Kowalski P
    Pathologica; 2013 Apr; 105(2):51-5. PubMed ID: 23946981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.